These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37858406)

  • 1. Reply to Eleonora Rosato, Riccardo Lombardo, Vincenzo Li Marzi, Enrico Finazzi Agrò, Cosimo De Nunzio, and Simone Albisinni's Letter to the Editor re: Rano Matta, Refik Saskin, Sarah Neu, et al. Predicting Mirabegron Treatment Response in Patients with Overactive Bladder: A Post Hoc Analysis of Data from Clinical Trials. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.04.001.
    Matta R
    Eur Urol Focus; 2023 Oct; ():. PubMed ID: 37858406
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Rano Matta, Refik Saskin, Sarah Neu, et al. Predicting Mirabegron Treatment Response in Patients with Overactive Bladder: A Post Hoc Analysis of Data from Clinical Trials. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.04.001.
    Rosato E; Lombardo R; Li Marzi V; Finazzi Agrò E; De Nunzio C; Albisinni S;
    Eur Urol Focus; 2023 Oct; ():. PubMed ID: 37806851
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Rano Matta, Refik Saskin, Sarah Neu, et al. Predicting Mirabegron Treatment Response in Patients with Overactive Bladder: A Post Hoc Analysis of Data from Clinical Trials. Eur Urol Focus 2023;9:957-65.
    Lin YH; Tsai HY; Tsao SH
    Eur Urol Focus; 2024 Mar; ():. PubMed ID: 38493068
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Carmen Gravina, Riccardo Lombardo, and Cosimo De Nunzio's Letter to the Editor re: Yash S. Khandwala, Simon John Christoph Soerensen, Shravan Morisetty, et al. The Association of Tissue Change and Treatment Success During High-intensity Focused Ultrasound Focal Therapy for Prostate Cancer. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.10.010.
    Sonn G; Khandwala Y
    Eur Urol Focus; 2023 Sep; 9(5):822-823. PubMed ID: 37012086
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Cosimo De Nunzio, Giacomo Novara, Rocco Damiano, Riccardo Bartoletti, Andrea Tubaro, and Vincenzo Ficarra's Letter to the Editor re: Giorgio Ivan Russo, Carmen Scandura, Marina Di Mauro, et al. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.01.002. New Evidence Changing Clinical Practice or Misunderstanding of Statistical Analyses? The Case of Serenoa repens and α-Blockers.
    Russo GI; Cacciamani G; Cocci A
    Eur Urol Focus; 2021 May; 7(3):662-663. PubMed ID: 32417122
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Carmen Gravina, Riccardo Lombardo, and Cosimo De Nunzio's Letter to the Editor re: Georges Mjaess, Alexandre Peltier, Jean-Baptiste Roche, et al. A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.04.008.
    Mjaess G; Roumeguère T; Diamand R
    Eur Urol Focus; 2024 Jan; 10(1):75-76. PubMed ID: 37543515
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Alessio Pecoraro, Vincenzo Li Marzi, Sergio Serni, and Riccardo Campi's Letter to the Editor re: Julia Dagnæs-Hansen, Gitte Hjartbro Kristensen, Hein V. Stroomberg, Søren Schwartz Sørensen, Martin Andreas Røder. Surgical Approaches and Outcomes in Living Donor Nephrectomy: A Systematic Review and Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.03.021.
    Dagnæs-Hansen J; Hjartbro Kristensen G; Stroomberg HV; Schwartz Sørensen S; Røder MA
    Eur Urol Focus; 2023 Jan; 9(1):218. PubMed ID: 35803853
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to Riccardo Lombardo, Sara Riolo, and Cosimo De Nunzio's Letter to the Editor re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.07.010.
    D'Andrea D; Soria F; Hurle R; Enikeev D; Kotov S; Régnier S; Xylinas E; Lusuardi L; Heidenreich A; Cai C; Frego N; Taraktin M; Ryabov M; Gontero P; Compérat E; Shariat SF;
    Eur Urol Oncol; 2023 Oct; ():. PubMed ID: 37865570
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to Luca Sarchi, Maria Chiara Sighinolfi, Simone Assumma, et al.'s Letter to Editor re: Carlo A. Bravi, Marco Paciotti, Eleonora Balestrazzi, et al. Outcomes of Robot-assisted Radical Prostatectomy with the Hugo RAS Surgical System: Initial Experience at a High-volume Robotic Center. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.01.008.
    Bravi CA; Mottrie A
    Eur Urol Focus; 2023 Sep; 9(5):843. PubMed ID: 36898944
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to Ryan S. Hsi, John M. Hollingsworth, and Tatuki Koyama's Letter to the Editor re: Lazaros Tzelves, Robert Geraghty, Riccardo Lombardo, et al. Duration of Follow-up and Timing of Discharge from Imaging Follow-up, in Adult Patients with Urolithiasis After Surgical or Medical Intervention: A Systematic Review and Meta-analysis from the European Association of Urology Guideline Panel on Urolithiasis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.06.016.
    Tzelves L; Geraghty R; Lombardo R; Davis NF; Petřík A; Neisius A; Gambaro G; Türk C; Thomas K; Somani B; Skolarikos A
    Eur Urol Focus; 2023 Mar; 9(2):381-382. PubMed ID: 36184536
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to Marco Moschini, Francesco Montorsi, Andrea Salonia, Giorgio Gandaglia and Alberto Briganti's Letter to the Editor Re: Francesco Soria, Matteo Rosazza, Simone Livoti, et al. Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non-muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.10.019.
    Soria F; Gontero P
    Eur Urol Focus; 2024 Jan; ():. PubMed ID: 38278711
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Juan Pablo Valdevenito, Marcio Augusto Averbeck, Sanjay Sinha, Enrico Finazzi-Agro, and Andrew Gammie's Letter to the Editor re: Karl H. Pang, Riccardo Campi, Salvador Arlandis, et al. Diagnostic Tests for Female Bladder Outlet Obstruction: A Systematic Review from the European Association of Urology Non-neurogenic Female LUTS Guidelines Panel. Eur Urol Focus 2022;8:1015-30.
    Pang KH; Campi R; Imran Omar M; Harding CK
    Eur Urol Focus; 2023 Jul; 9(4):629-630. PubMed ID: 36737363
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Lazaros Tselves, Robert Geraghty, Riccardo Lombardo, et al. Duration of Follow-up and Timing of Discharge from Imaging Follow-up, in Adult Patients with Urolithiasis After Surgical or Medical Intervention: A Systematic Review and Meta-analysis from the European Association of Urology Guideline Panel on Urolithiasis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.06.016.
    Hsi RS; Hollingsworth JM; Koyama T
    Eur Urol Focus; 2023 Mar; 9(2):383. PubMed ID: 36182575
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to Shun Wan, Kun-peng Li, and Li Yang's Letter to the Editor re: Jordan M. Rich, Kennedy E. Okhawere, Charles Nguyen, et al. Transperitoneal Versus Retroperitoneal Single-port Robotic-assisted Partial Nephrectomy: An Analysis from the Single Port Advanced Research Consortium. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.06.004.
    Rich JM; Okhawere KE; Razdan S; Badani KK
    Eur Urol Focus; 2023 Sep; ():. PubMed ID: 37739915
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to Nikolaos Grivas, Sanchia Goonewardene, Wouter Everaerts, Nikolaos Kalampokis's Letter to the Editor re: Andrea Mari, Riccardo Tellini, Francesco Porpiglia, et al. Perioperative and Mid-term Oncological and Functional Outcomes After Partial Nephrectomy for Complex (PADUA Score ≥10) Renal Tumors: A Prospective Multicenter Observational Study (the RECORD2, Project). Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.07.004.
    Mari A; Tellini R; Ficarra V; Carini M; Minervini A;
    Eur Urol Focus; 2021 Sep; 7(5):1212-1213. PubMed ID: 33384273
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re: Cosimo De Nunzio, Benjamin Brucker, Thomas Bschleipfer, et al. Beyond Antimuscarinics: A Review of Pharmacological and Interventional Options for Overactive Bladder Management in Men. Eur Urol 2021;79:492-504.
    De Nunzio C; Brucker B; Bschleipfer T; Cornu JN; Drake MJ; Fusco F; Gravas S; Oelke M; Peyronnet B; Tutolo M; van Koeveringe G; Madersbacher S
    Eur Urol; 2021 May; 79(5):e147-e148. PubMed ID: 33685837
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to Davide Rosati, Riccardo Lombardo, Cosimo De Nunzio, Constantino Leonardo, and Andrea Tubaro's Words of Wisdom re: Transperineal Interstitial Laser Ablation of the Prostate, A Novel Option for Minimally Invasive Treatment of Benign Prostatic Obstruction. Eur Urol 2021;80:673-4.
    De Rienzo G; Minafra P; Ditonno P
    Eur Urol; 2022 Apr; 81(4):e100-e101. PubMed ID: 35101305
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to Vikas Mishra's Letter to the Editor, re: Gregory W. Hosier, Thomas McGregor, Darren Beiko, et al. Persistent Opioid Use Among Patients with Urolithiasis: A Population based Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2019.08.011.
    Hosier GW; McGregor T; Beiko D; Jaeger M; Booth C; Whitehead M; Robert Siemens D
    Eur Urol Focus; 2021 Jul; 7(4):897. PubMed ID: 32327354
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to Giorgio Gandaglia, Alberto Briganti, Daniele Raggi, et al's Letter to the Editor re: Philipp Mandel, Benedikt Hoeh, Mike Wenzel, et al. Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.08.007.
    Hoeh B; Chun FKH; Mandel P
    Eur Urol Focus; 2023 Feb; ():. PubMed ID: 36813619
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to Rodolfo Montironi, Marina Scarpelli, Alessia Cimadamore, and Gregor Mikuz's Letter to the Editor re: Theo van der Kwast, Fredrik Liedberg, Peter C. Black, et al. International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.017. Focus on Our Personal Recollections and Observations.
    van der Kwast T; Van Rhijn B; Kamat A; Cheng L
    Eur Urol Focus; 2022 May; 8(3):885-886. PubMed ID: 33992577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.